LAUSR

Belmonte, L., Parodi, C., Bar e, P., Malbran, A., Ruibal-Ares, B. & de Bracco, M.M. de E. (2007) Factors involved in the generation of memory CD8 + T cells in patients with X-linked lymphoproliferative disease (XLP). Clinical and Experimental Immunology, 147, 456–464. Belmonte, L., Parodi, C., Bast on, M., Coraglia, A., Felippo, M., Bar e, P., Malbran, A., Ruibal-Ares, B. & de Bracco, M.M. de E. (2009) Increased lymphocyte viability after non-stimulated peripheral blood mononuclear cell (PBMC) culture in patients with X-linked lymphoproliferative disease (XLP). Clinical Immunology, 133, 86–94. Cohen, J.I., Jaffe, E.S., Dale, J.K., Pittaluga, S., Heslop, H.E., Rooney, C.M., Gottschalk, S., Bollard, C.M., Rao, V.K., Narques, A., Burbele, P.D., Turk, S.P., Fulton, R., Wayne, A.S., Little, R.F., Cairo, M.S., El-Mallawany, N.K., Fowler, D., Sportes, C., Bishop, M.R., Wilson, W. & Strauss, S.E. (2015) Characterization and treatment of chronic active Epstein-Barr virus disease: a 28year experience in the United States. Blood, 117, 5835–5849. Coraglia, A., Belmonte, L., Parodi, C., Bast on, M., Bar e, P., Ruibal-Ares, B., Galassi, N. & de Bracco, M.M. de E. (2010) B-lymphocyte memory in X-linked lymphoproliferative disease (XLP). Current Immunology Reviews, 6, 323– 328. Czar, M.J., Kersh, E.N., Mijares, L.A., Lanier, G., Lewis, J., Yap, G., Chen, A., Sher, A., Duckett, C.S., Ahmed, R. & Schwartzberg, P.L. (2001) Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/ SAP. Proceedings of the National Academy of Sciences U.S.A., 98, 7449–7454. Malbran, A., Belmonte, L., Ruibal-Ares, B., Bar e, P., Massud, I., Parodi, C., Felippo, M., Hodinka, R., Haines, K., Nichols, K.E. & de Bracco, M.M. (2001) Loss of circulating CD27 + memory B cells and CCR4 + T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Blood, 103, 1625–1631. Milone, M.C., Tsai, D.E., Hodinka, R.L., Silverman, L.B., Malbran, A., Wasik, M.A. & Nichols, K.E. (2005) Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood, 105, 994–996. Nichols, K.E., Harkin, D.P., Levitz, S., Krainer, M., Kolquist, K.A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., Buckler, A.J., Wise, C., Ashley, J., Lovett, M., Valentine, M.B., Look, A.T., Gerald, W., Housman, D.E. & Haber, D.A. (1998) Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proceedings of the National Academy of Sciences U.S.A., 95, 13765–13770. Paquin Proulx, D., Aubin, E., Lemieux, R. & Bazin, R. (2010) Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg). Clinical Immunology, 135, 422– 429. Qi, H., Cannons, J.L., Klauschen, F., Schwartzberg, P.L. & Germain, R.N. (2008) SAP-controlled TB interactions underlie germinal center formation. Nature, 455, 764–769.